Search Results
You are looking at 1-10 of 73
![<bold>Figure 2</bold>](/view/journals/anpr/64/3/inline-i0003-3006-64-3-127-f02.png)
Study population: disposition of subjects. LB indicates liposomal bupivacaine; NRS, numeric rating scale; and ITT, intent-to-treat.
![<bold>Figure 3.</bold>](/view/journals/anpr/60/4/inline-i0003-3006-60-4-178-f03.png)
Diagram of liposomal bupivacaine particle in DepoFoam vehicle. Image supplied courtesy of Pacira Pharmaceuticals Inc.
![](/view/journals/anpr/69/4/inline-i1878-7177-69-4-9-f01.png)
![](/view/journals/anpr/52/4/inline-i0003-3006-52-4-132-f01.gif)
![<bold>Figure 1</bold>](/view/journals/anpr/64/3/inline-i0003-3006-64-3-127-f01.png)
Infiltration technique. Arrows denote illustrative infiltration sites. Images courtesy of Stuart E. Lieblich, DMD.
![<bold>Figure 3</bold>](/view/journals/anpr/64/3/inline-i0003-3006-64-3-127-f03.png)
A. Cumulative AUC of NRS pain intensity scores at 24, 48, 72, and 96 hours postsurgery (primary efficacy [ITT] population). AUC indicates area under the curve; NRS, numeric rating scale; and ITT, intent-to-treat. B. Cumulative AUC of NRS pain intensity scores at 24, 48, 72, and 96 hours postsurgery (per-protocol population). *P < .05 versus placebo.
![<bold>Figure 4</bold>](/view/journals/anpr/64/3/inline-i0003-3006-64-3-127-f04.png)
A. Mean scores for subjects' satisfaction with postsurgical pain control assessed using a 5-point Likert scale where 1 = extremely dissatisfied and 5 = extremely satisfied (primary efficacy [intent-to-treat] population). B. Mean scores for subjects' satisfaction with postsurgical pain control assessed using a 5-point Likert scale where 1 = extremely dissatisfied and 5 = extremely satisfied (per-protocol population).